Abstract
Early detection of oral cancer necessitates a minimally invasive, tissue-specific diagnostic tool that facilitates screening/surveillance. Brush biopsy, though minimally invasive, demands skilled cyto-pathologist expertise. In this study, we explored the clinical utility/efficacy of a tele-cytology system in combination with Artificial Neural Network (ANN) based risk-stratification model for early detection of oral potentially malignant (OPML)/malignant lesion. A portable, automated tablet-based tele-cytology platform capable of digitization of cytology slides was evaluated for its efficacy in the detection of OPML/malignant lesions (n = 82) in comparison with conventional cytology and histology. Then, an image pre-processing algorithm was established to segregate cells, ANN was trained with images (n = 11,981) and a risk-stratification model developed. The specificity, sensitivity and accuracy of platform/ stratification model were computed, and agreement was examined using Kappa statistics. The tele-cytology platform, Cellscope, showed an overall accuracy of 84-86% with no difference between tele-cytology and conventional cytology in detection of oral lesions (kappa, 0.67-0.72). However, OPML could be detected with low sensitivity (18%) in accordance with the limitations of conventional cytology. The integration of image processing and development of an ANN-based risk stratification model improved the detection sensitivity of malignant lesions (93%) and high grade OPML (73%), thereby increasing the overall accuracy by 30%. Tele-cytology integrated with the risk stratification model, a novel strategy established in this study, can be an invaluable Point-of-Care (PoC) tool for early detection/screening in oral cancer. This study hence establishes the applicability of tele-cytology for accurate, remote diagnosis and use of automated ANN-based analysis in improving its efficacy.
Highlights
Oral cancer accounts for 30% of cancer-related death in low and middle-income countries [1]
We explored the clinical utility/efficacy of this portable, automated system in combination with Convolutional Neural Network (CNN) for classification of atypical cells [21] and subsequent training of the Artificial Neural Network (ANN), Inception V3 architecture [22]
We evaluated the efficacy of a tele-cytology platform for oral cancer screening and developed a risk stratification model using an Artificial Neural Network
Summary
Oral cancer accounts for 30% of cancer-related death in low and middle-income countries [1]. Due to the invasive nature of biopsies and lack of related expertise, this is neither feasible nor readily utilized as a screening tool. These issues are owed to the scarcity of trained specialists such as pathologists or surgeons in low-resource-settings. The studies shows that less than 65% of primary care centres have access to reliable pathology services in low-middle income countries[1,2,3]. A tele-cytology platform that provides reliable, remote connectivity to frontline health workers (FHW) and specialists may improve early detection of oral cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.